NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹9.68
-0.69%
NAV as on 17 Nov 24, 12:00 AM
very high risk
global other
fof
NAV as on 17 Nov 24, 12:00 AM
very high risk
global other
fof
33.56%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
0.22%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the Mirae Asset Hang Seng TECH ETF Fund of Fund Growth scheme from Mirae Asset Investment Managers (India) Private Limited. It is a Global - Other mutual fund scheme that predominantly invests in Global - Other stocks of companies. Launched on Dec 2021, Mirae Asset Hang Seng TECH ETF Fund of Fund Growth is Global - Other fund of its category with 88.54 Cr fund under management as on Nov 2024. The expense ratio of this fund is less than that of most other Fund category Global - Other funds.
The investment objective of the scheme is to provide long-term capital appreciation from a portfolio investing predominantly in units of Mirae Asset Hang Seng TECH ETF. There is no assurance that the investment objective of the Scheme will be realized.
Mirae Asset Hang Seng TECH ETF
99.55%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
---|---|---|
Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return
very high risk | fof
13.6%
very high risk | equity
13.2%
very high risk | fof
5.3%